Every earnings call for SHILPAMED — management tone, guidance, KPIs and promise tracking, quarter by quarter.
SHILPAMED · 5 transcripts · Healthcare · latest Q4 FY26Shilpa Medicare Limited has 5 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue ₹439 cr (+30% YoY); EBITDA ₹121 cr (+40% YoY); EBITDA Margin 28% (+2% YoY). Highest ever quarterly revenue of ₹439 crores, up 30% YoY.
Read full transcript & analysisRevenue ₹411 cr (+28% YoY); EBITDA ₹115 cr (+41% YoY); EBITDA Margin 28% (+2% YoY). Revenue of ₹411 crores, up 28% YoY.
Read full transcript & analysisRevenue ₹372 cr (+7% YoY); EBITDA ₹110 cr (+21% YoY); EBITDA Margin 30% (+4% YoY). Highest ever quarterly EBITDA of ₹110 crores, up 21% YoY.
Read full transcript & analysisRevenue ₹328 cr (+9% YoY); EBITDA ₹98 cr (+18% YoY); EBITDA Margin 30%. Revenue of ₹328 crores, up 9% YoY.
Read full transcript & analysisRevenue ₹338 cr (+15% YoY); EBITDA ₹84 cr (+15% YoY); EBITDA Margin 25%. Revenue of ₹338 crores, up 15% YoY in Q4 FY25.
Read full transcript & analysis